[HTML][HTML] Late effects of radiation therapy in the head and neck region
JS Cooper, K Fu, J Marks, S Silverman - International Journal of Radiation …, 1995 - Elsevier
The head and neck region is composed of numerous structures, each with an inherent
response to radiation that is largely governed by the presence or absence of mucosa, salivary …
response to radiation that is largely governed by the presence or absence of mucosa, salivary …
Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience
JS Cooper, TF Pajak, P Rubin, L Tupchong… - International Journal of …, 1989 - Elsevier
The development of second malignant tumors (SMTs), in patients who have had their first
tumor treated successfully, represents a serious limitation of current therapeutic strategies for …
tumor treated successfully, represents a serious limitation of current therapeutic strategies for …
[HTML][HTML] Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
JS Cooper, TF Pajak, AA Forastiere… - … England Journal of …, 2004 - Mass Medical Soc
Background Despite the use of resection and postoperative radiotherapy, high-risk squamous-cell
carcinoma of the head and neck frequently recurs in the original tumor bed. We tested …
carcinoma of the head and neck frequently recurs in the original tumor bed. We tested …
The CDF detector: an overview
…, D Cline, D Connor, M Contreras, J Cooper… - Nuclear Instruments and …, 1988 - Elsevier
The Collider Detector at Fermilab (CDF) is a 5000 t magnetic detector built to study 2 TeV p
p collisions at the Fermilab Tevatron. Event analysis is based on charged particle tracking, …
p collisions at the Fermilab Tevatron. Event analysis is based on charged particle tracking, …
[HTML][HTML] Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
…, DJ Lee, A Leaf, J Ensley, J Cooper - … England Journal of …, 2003 - Mass Medical Soc
Background Induction chemotherapy with cisplatin plus fluorouracil followed by radiotherapy
is the standard alternative to total laryngectomy for patients with locally advanced laryngeal …
is the standard alternative to total laryngectomy for patients with locally advanced laryngeal …
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
…, M LeBlanc, PG Giri, KK Fu, J Cooper… - Journal of clinical …, 1998 - ascopubs.org
PURPOSE The Southwest Oncology Group (SWOG) coordinated an Intergroup study with
the participation of Radiation Therapy Oncology Group (RTOG), and Eastern Cooperative …
the participation of Radiation Therapy Oncology Group (RTOG), and Eastern Cooperative …
[HTML][HTML] Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
…, J Brindle, V Vaitkevicius, J Cooper… - … England Journal of …, 1992 - Mass Medical Soc
Background. The efficacy of conventional treatment with surgery and radiation for cancer of
the esophagus is limited. The median survival is less than 10 months, and less than 10 …
the esophagus is limited. The median survival is less than 10 months, and less than 10 …
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC …
J Bernier, JS Cooper, TF Pajak… - Head & Neck …, 2005 - Wiley Online Library
Background. In 2004, level I evidence was established for the postoperative adjuvant
treatment of patients with selected high‐risk locally advanced head and neck cancers, with the …
treatment of patients with selected high‐risk locally advanced head and neck cancers, with the …
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01)
JS Cooper, MD Guo, A Herskovic, JS Macdonald… - Jama, 1999 - jamanetwork.com
ContextCarcinoma of the esophagus traditionally has been treated by surgery or radiation
therapy (RT), but 5-year overall survival rates have been only 5% to 10%. We previously …
therapy (RT), but 5-year overall survival rates have been only 5% to 10%. We previously …
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard …
…, TL Phillips, AS Garden, JA Ridge, JS Cooper… - International Journal of …, 2000 - Elsevier
Purpose: The optimal fractionation schedule for radiotherapy of head and neck cancer has
been controversial. The objective of this randomized trial was to test the efficacy of …
been controversial. The objective of this randomized trial was to test the efficacy of …